TAPBPL
Basic information
Region (hg38): 12:6451690-6466517
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TAPBPL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 19 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 1 | 0 |
Variants in TAPBPL
This is a list of pathogenic ClinVar variants found in the TAPBPL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-6453067-A-G | not specified | Uncertain significance (Sep 01, 2021) | ||
12-6453081-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
12-6453284-C-G | not specified | Uncertain significance (Oct 27, 2022) | ||
12-6453286-T-C | not specified | Uncertain significance (May 31, 2023) | ||
12-6453473-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
12-6453527-C-T | not specified | Uncertain significance (Mar 27, 2023) | ||
12-6453645-C-T | not specified | Uncertain significance (May 17, 2023) | ||
12-6453677-A-C | Marfanoid habitus and intellectual disability | Uncertain significance (-) | ||
12-6453708-G-A | not specified | Likely benign (Dec 16, 2023) | ||
12-6453713-G-A | not specified | Uncertain significance (Jun 29, 2022) | ||
12-6457472-A-T | not specified | Uncertain significance (Oct 04, 2022) | ||
12-6457489-G-A | not specified | Uncertain significance (Oct 20, 2021) | ||
12-6457523-G-A | not specified | Uncertain significance (Mar 27, 2023) | ||
12-6457588-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
12-6457589-G-A | not specified | Uncertain significance (Apr 13, 2023) | ||
12-6458681-C-T | not specified | Uncertain significance (Jun 07, 2023) | ||
12-6458936-T-C | not specified | Uncertain significance (Dec 16, 2021) | ||
12-6460857-C-T | not specified | Uncertain significance (Nov 22, 2022) | ||
12-6462085-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
12-6462127-C-T | not specified | Uncertain significance (Oct 06, 2021) | ||
12-6462840-G-A | Benign/Likely benign (Jan 01, 2024) | |||
12-6462882-A-G | Myasthenic syndrome, congenital, 25, presynaptic • Spastic ataxia 1 | Benign (Dec 05, 2021) | ||
12-6463025-T-C | Benign (May 15, 2021) | |||
12-6464474-G-A | Spastic paraplegia | Uncertain significance (Aug 22, 2022) | ||
12-6464476-A-G | Spastic paraplegia | Likely benign (Aug 16, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TAPBPL | protein_coding | protein_coding | ENST00000266556 | 7 | 14828 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.31e-10 | 0.254 | 125623 | 0 | 124 | 125747 | 0.000493 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.779 | 231 | 267 | 0.866 | 0.0000144 | 2975 |
Missense in Polyphen | 47 | 60.872 | 0.77212 | 725 | ||
Synonymous | 0.102 | 113 | 114 | 0.988 | 0.00000665 | 1013 |
Loss of Function | 0.779 | 17 | 20.8 | 0.816 | 0.00000132 | 186 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000845 | 0.000841 |
Ashkenazi Jewish | 0.000417 | 0.000397 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.00125 | 0.00125 |
European (Non-Finnish) | 0.000254 | 0.000237 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.00115 | 0.00111 |
Other | 0.000499 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the antigen processing and presentation pathway, which binds to MHC class I coupled with beta2- microglobulin/B2M. Association between TAPBPR and MHC class I occurs in the absence of a functional peptide-loading complex (PLC). Expression seems to slow down and down-regulate MHC class I surface expression. {ECO:0000269|PubMed:23401559}.;
Recessive Scores
- pRec
- 0.0840
Intolerance Scores
- loftool
- 0.883
- rvis_EVS
- 0.98
- rvis_percentile_EVS
- 90.39
Haploinsufficiency Scores
- pHI
- 0.0481
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.402
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.368
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tapbpl
- Phenotype
Gene ontology
- Biological process
- immune system process;negative regulation of antigen processing and presentation of peptide antigen via MHC class I
- Cellular component
- Golgi membrane;endoplasmic reticulum membrane;plasma membrane;integral component of membrane
- Molecular function
- protein binding;protein-containing complex binding